[Preoperative intra-arterial infusion chemotherapy in locally advanced primary breast cancer-tissue concentrations of 5-fluorouracil and adriamycin, and the histological evaluation]. 1988

H Ishikawa, and N Murayama, and M Kasahara, and M Ikoma, and Y Takenaka, and H Yoshida, and A Shimada, and M Watanabe
Dept. of Surgery, Keiyu General Hospital.

The effect of preoperative intra-arterial infusion of mitomycin C, 5-fluorouracil (5-FU) and adriamycin (ADM) were studied in seven patients with locally advanced breast cancer, including five inflammatory carcinomas, and a patient with stromal sarcoma of the breast. Reducing rate of the primary tumor of more than 30% was observed in all cases, and remarkable degenerative changes of tumor cells were histologically noted in six out of eight surgical specimens. The tissue concentrations of 5-FU and ADM were also studied in five breast cancer patients. There was no correlation between the concentration of 5-FU or ADM and histological effect. In intra-arterial infusion, ADM seemed to have a high affinity to the regional lymphnode and breast tumor, compared to normal breast tissue and might also be applicable to the control of lymphnode metastasis. Three out of six cases which received radical mastectomy subsequently had recurrence except in the regional lymphnodes and the prognosis was unsatisfactory (5 year survival was 2/4). Other alternative or multi-disciplinary treatment seems to be necessary for improving the survival rate.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D011300 Preoperative Care Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed) Care, Preoperative,Preoperative Procedure,Preoperative Procedures,Procedure, Preoperative,Procedures, Preoperative
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001940 Breast In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES. Breasts
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell

Related Publications

H Ishikawa, and N Murayama, and M Kasahara, and M Ikoma, and Y Takenaka, and H Yoshida, and A Shimada, and M Watanabe
May 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
H Ishikawa, and N Murayama, and M Kasahara, and M Ikoma, and Y Takenaka, and H Yoshida, and A Shimada, and M Watanabe
August 1985, Gan to kagaku ryoho. Cancer & chemotherapy,
H Ishikawa, and N Murayama, and M Kasahara, and M Ikoma, and Y Takenaka, and H Yoshida, and A Shimada, and M Watanabe
November 1975, Cancer,
H Ishikawa, and N Murayama, and M Kasahara, and M Ikoma, and Y Takenaka, and H Yoshida, and A Shimada, and M Watanabe
December 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
H Ishikawa, and N Murayama, and M Kasahara, and M Ikoma, and Y Takenaka, and H Yoshida, and A Shimada, and M Watanabe
November 1983, Gan to kagaku ryoho. Cancer & chemotherapy,
H Ishikawa, and N Murayama, and M Kasahara, and M Ikoma, and Y Takenaka, and H Yoshida, and A Shimada, and M Watanabe
August 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
H Ishikawa, and N Murayama, and M Kasahara, and M Ikoma, and Y Takenaka, and H Yoshida, and A Shimada, and M Watanabe
January 1997, Acta oncologica (Stockholm, Sweden),
H Ishikawa, and N Murayama, and M Kasahara, and M Ikoma, and Y Takenaka, and H Yoshida, and A Shimada, and M Watanabe
August 1991, Gan to kagaku ryoho. Cancer & chemotherapy,
H Ishikawa, and N Murayama, and M Kasahara, and M Ikoma, and Y Takenaka, and H Yoshida, and A Shimada, and M Watanabe
May 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
H Ishikawa, and N Murayama, and M Kasahara, and M Ikoma, and Y Takenaka, and H Yoshida, and A Shimada, and M Watanabe
September 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!